These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30643324)

  • 21. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    Bajgoric S; Samra K; Chandrapalan S; Gautam N
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Legalization of Marijuana in Colorado: The Impact: Volume 8, September 2021.
    Rocky Mountain High Intensity Drug Trafficking Area Program
    Mo Med; 2021; 118(6):534-535. PubMed ID: 34924618
    [No Abstract]   [Full Text] [Related]  

  • 23. Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use.
    Rosenthal J; Howell M; Earl V; Malik M
    Am J Med; 2021 Dec; 134(12):e582-e583. PubMed ID: 34343506
    [No Abstract]   [Full Text] [Related]  

  • 24. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary on van der Pol et al. (2014): Reconsidering the association between cannabis exposure and dependence.
    Temple EC
    Addiction; 2014 Jul; 109(7):1110-1. PubMed ID: 24903289
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dutch government pressured to reconsider planned re-scheduling of cannabis in drug law.
    Lemmens P
    Addiction; 2014 Oct; 109(10):1761-2. PubMed ID: 25163714
    [No Abstract]   [Full Text] [Related]  

  • 28. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation.
    Wolff K; Johnston A
    Drug Test Anal; 2014; 6(1-2):143-54. PubMed ID: 24327278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dronabinol-Induced Acute Altered Mental Status in an Elderly Patient.
    Sinha A; Singh P; Kupfer Y
    Am J Ther; 2018; 25(4):e502-e503. PubMed ID: 28452845
    [No Abstract]   [Full Text] [Related]  

  • 30. Validation of self-reported cannabis dose and potency: an ecological study.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2013 Oct; 108(10):1801-8. PubMed ID: 23627816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Public Health Framework of Legalized Marijuana in Colorado.
    Ghosh T; Van Dyke M; Maffey A; Whitley E; Gillim-Ross L; Wolk L
    Am J Public Health; 2016 Jan; 106(1):21-7. PubMed ID: 26562117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey.
    Van der Linden T; Silverans P; Verstraete AG
    Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Risks of Marijuana Use During Pregnancy.
    Volkow ND; Compton WM; Wargo EM
    JAMA; 2017 Jan; 317(2):129-130. PubMed ID: 27992628
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana.
    Cermak TL
    J Psychoactive Drugs; 2016; 48(1):31-40. PubMed ID: 26881331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
    Hall W; Degenhardt L
    BMJ; 2015 Mar; 350():h1205. PubMed ID: 25739398
    [No Abstract]   [Full Text] [Related]  

  • 36. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
    Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
    Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
    Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.
    Zaurova M; Hoffman RS; Vlahov D; Manini AF
    J Med Toxicol; 2016 Dec; 12(4):335-340. PubMed ID: 27255136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
    Niesink RJ; Rigter S; Koeter MW; Brunt TM
    Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unravelling the landscape of
    Preto MC; Kortas GT; Blaas IK; Lassi DLS; Waisman Campos M; Torales J; Ventriglio A; de Azevedo-Marques Périco C; de Andrade AG; Castaldelli-Maia JM
    Int Rev Psychiatry; 2023; 35(5-6):434-449. PubMed ID: 38299652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.